For those who are high-risk and NED, and can travel to the clinical trial site, this trial might be worthwhile. You can find it at the clinicaltrials.gov website.
Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer
This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) June 2006
Sponsors and Collaborators:
Sidney Kimmel Comprehensive Cancer Center National Cancer Institute (NCI)
Information provided by:National Cancer Institute (NCI)ClinicalTrials.gov Identifier:NCT00334542
Purpose
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of simvastatin may keep cancer from coming back in women who are at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.
PURPOSE: This phase II trial is studying how well simvastatin works in preventing a new breast cancer in women at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.
Linear Mode
